StockWatch
·

Monte Rosa Therapeutics, Inc.

Ticker: 1826457

P/L Snapshot

Q3 FY26 · consolidated

vs Q2 FY26·vs Q3 FY25
Revenue
54.37
+506.1%+325.8%
Expenditure
56.31
-3.1%+23.1%
Net Profit
3.06
+107.1%+111.3%
OPM %
-3.57%
+96.43pp+96.43pp

Shareholding

Pattern breakdown

P/L Trends

(in millions)

RevenueExpenditureNet Profit
-60.03-19.9120.2260.34100.46Q1 FY24Q2 FY24Q3 FY24Q1 FY25Q2 FY25Q3 FY25Q1 FY26Q2 FY26Q3 FY26
Price Chart
Latest News